Influence of altered apoptosis in human lymphoblastoid cell lines on micronucleus frequency

Toxicology Letters

Volumn 147, Issue 2, 2004, Pages 187-195

  Vukicevic, Vladimir ^a   Kampfinger, Katja ^a   Stopper, Helga ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Apoptosis; bcl 2; Micronuclei; Pifithrin

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ETOPOSIDE; GYRASE INHIBITOR; OLIGONUCLEOTIDE; PIFITHRIN ALPHA; PROTEIN BCL 2; PROTEIN INHIBITOR; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL; APOPTOSIS; ARTICLE; CELL DIVISION; CELL MUTANT; CELL SURVIVAL; CHROMOSOME ABERRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DAMAGE; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GENETICS; GENOTOXICITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOLOGY; KNOCKOUT GENE; LYMPHATIC LEUKEMIA; LYMPHOBLASTOID CELL LINE; MICRONUCLEUS; MICRONUCLEUS TEST; MOUSE; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROTO ONCOGENE; STRESS; TUMOR CELL LINE; WESTERN BLOTTING; WILD TYPE;

EID: 1642522084     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2003.11.005     Document Type: Article

References (22)

1. Abend M., Frombeck S., Van Beuningen D. Indications for an active process underlying spontaneous and radiation-induced micronucleation in L929 cells. Int. J. Radiat. Biol. 75(12):1999;1567-1578.
2. Bassi L., Carloni M., Fonti E., Palma de la Pena N., Meschini R., Palitti F. Pifithrin-alpha, an inhibitor of p53, enhances the genetic instability induced by etoposide (VP16) in human lymphoblastoid cells treated in vitro. Mutat. Res. 499(2):2002;163-176.
3. Boos G., Stopper H. Genotoxicity of several clinically used topoisomerase II inhibitors. Toxicol. Lett. 116(1-2):2000;7-16.
4. Decordier I., Dillen L., Cundari E., Kirsch-Volders M. Elimination of micronucleated cells by apoptosis after treatment with inhibitors of microtubules. Mutagen. 17(4):2002;337-344.
5. Gurova K.V., Gudkov A.V. Paradoxical role of apoptosis in tumor progression. J. Cell Biochem. 88(1):2003;128-137.
6. Hartwell L.H., Weinert T.A. Checkpoints: controls that ensure the order of cell cycle events. Science. 246(4930):1989;629-634.
7. Hopkins-Donaldson S., Cathomas R., Simoes-Wust A.P., Kurtz S., Belyanskya L., Stahel R.A., Zangemeister-Wittke U. Induction of apoptosis and chemosensitization of mesothelioma cells by Bcl-2 and Bcl-xL antisense treatment. Int. J. Cancer. 106(2):2003;160-166.
8. Johnstone R.W., Ruefli A.A., Lowe S.W. Apoptosis: a link between cancer genetics and chemotherapy. Cell. 108(2):2002;153-164.
9. Kaji A., Zhang Y., Nomura M., Bode A.M., Ma W.Y., She Q.B., Dong Z. Pifithrin-alpha promotes p53-mediated apoptosis in JB6 cells. Mol. Carcinog. 37(3):2003;138-148.
10. Komarov P.G., Komarova E.A., Kondratov R.V., Christov-Tselkov K., Coon J.S., Chernov M.V., Gudkov A.V. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science. 285(5434):1999;1733-1737.
11. Komarova E.A., Neznanov N., Komarov P.G., Chernov M.V., Wang K., Gudkov A.V. p53 inhibitor pifithrin alpha can suppress heat shock and glucocorticoid signaling pathways. J. Biol. Chem. 278(18):2003;15465-15468.
12. Livingstone L.R., White A., Sprouse J., Livanos E., Jacks T., Tlsty T.D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53a. Cell. 70(6):1992;923-935.
13. Meintieres S., Biola A., Pallardym M., Marzin D. Using CTLL-2 and CTLL-2 bcl2 cells to avoid interference by apoptosis in the in vitro micronucleus test. Environ. Mol. Mutagen. 41(1):2003;14-27.
14. Miller B., Potter-Locher F., Seelbach A., Stopper H., Utesch D., Madle S. Evaluation of the in vitro micronucleus test as an alternative to the in vitro chromosomal aberration assay: position of the GUM Working Group on the in vitro micronucleus test. Mutat. Res. 410(1):1998;81-116.
15. Pietenpol J.A., Stewart Z.A. Cell cycle checkpoint signaling: cell cycle arrest versus apoptosis. Toxicology. 181-182:2002;475-481.
16. Proietti De Santis L., Balajee A.S., Lorenti Garcia C., Pepe G., Worboys A.M., Palitti F. Inhibition of p53, p21 and Bax by pifithrin-alpha does not affect UV induced apoptotic response in CS-B cells. DNA Rep. 2(8):2003;891-900.
17. Samorapoompichit P., Steiner M., Lucas T., Wachtler F., Schedled A., Sperr W.R., Valent P. Induction of apoptosis in the human mast cell leukemia cell line HMC-1 by various antineoplastic drugs. Leuk. Lymph. 44(3):2003;509-515.
18. Schafer T., Scheuer C., Roemer K., Menger M.D., Vollmar B. Inhibition of p53 protects liver tissue against endotoxin-induced apoptotic and necrotic cell death. FASEB J. 17(6):2003;660-667.
19. Schwartz J.L., Jordan R., Evans H.H., Lenarczyk M., Liber H. The TP53 dependence of radiation-induced chromosome instability in human lymphoblastoid cells. Radiat. Res. 159(6):2003;730-736.
20. Vukicevic, V., Kampfinger, K., Stopper, H., 2003. Estrogenic stimulation and transfection with anti-apoptotic protein influence genomic stability in human ovarial BG-1 cells (in preparation).
21. Yin Y., Tainsky M.A., Bischoff F.Z., Strong L.C., Wahl G.M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell. 70(6):1992;937-948.
22. Zhang Y., Lei X.Y. Effect of bcl-2 antisense oligodeoxynucleotides on drug sensitivity of leukemic cells. Hematol. J. 4(3):2003;187-197.